Targets for the Treatment of Erectile Dysfunction: Is NO/cGMP Still the Answer?
Recent Patents on Cardiovascular Drug Discovery · 01.06.2007 · 2 (2) · 119-132
DOI: 10.2174/157489007780832579 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Recent Patents on Cardiovascular Drug Discovery, erschienen am 01.06.2007. Verfasst von Romulo Leite und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Medical College of Georgia, Augusta, GA 30912, USA. rleite@mcg.edu. Hauptthemen laut MEDLINE: Erectile Dysfunction. Die Arbeit wurde bisher 29-mal zitiert (Crossref). Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Medical College of Georgia, Augusta, GA 30912, USA. rleite@mcg.edu
Förderung
- NHLBI NIH HHS
Zitieren
APA
Leite, R., Giachini, F. R., Carneiro, F. S., Nunes, K. P., Tostes, R. C., & Webb, R. C. (2007). Targets for the Treatment of Erectile Dysfunction: Is NO/cGMP Still the Answer?. Recent Patents on Cardiovascular Drug Discovery, 2(2), 119-132. https://doi.org/10.2174/157489007780832579
Vancouver
Leite R, Giachini FR, Carneiro FS, Nunes KP, Tostes RC, Webb RC. Targets for the Treatment of Erectile Dysfunction: Is NO/cGMP Still the Answer?. Recent Patents on Cardiovascular Drug Discovery. 2007;2(2):119-132. doi:10.2174/157489007780832579
BibTeX
@article{Leite2007,
author = {Leite, Romulo and Giachini, Fernanda R C and Carneiro, Fernando S and Nunes, Kênia P and Tostes, Rita C and Webb, Robert C},
title = {Targets for the Treatment of Erectile Dysfunction: Is NO/cGMP Still the Answer?},
journal = {Recent Patents on Cardiovascular Drug Discovery},
year = {2007},
volume = {2},
number = {2},
pages = {119--132},
doi = {10.2174/157489007780832579}
}
EUVIMED